Montclair, NJ, United States of America

Juan D Arredondo

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Juan D Arredondo

Introduction

Juan D Arredondo is a notable inventor based in Montclair, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of NK1 antagonists. With a total of five patents to his name, his work has the potential to impact the treatment of various disorders.

Latest Patents

Among his latest patents, one notable invention is a NK1 antagonist characterized by a specific formula. This compound is designed to be useful in treating a range of disorders, including emesis, depression, anxiety, and cough. The patent also covers pharmaceutical compositions, methods of treatment, and combinations with other agents, showcasing the versatility and applicability of his innovations.

Career Highlights

Throughout his career, Juan D Arredondo has worked with prominent companies in the pharmaceutical industry. He has been associated with Opko Health, Inc. and Schering Corporation, where he has contributed to various research and development projects. His expertise in the field has allowed him to make significant advancements in drug formulation and therapeutic applications.

Collaborations

Juan has collaborated with esteemed colleagues such as Sunil Paliwal and Gregory A Reichard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of his work.

Conclusion

Juan D Arredondo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…